372
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?

, , &
Pages 265-275 | Published online: 12 Aug 2009

References

  • RosamondWFlegalKFurieKHeart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation20081174e25e14618086926
  • NeatonJDWentworthDSerum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research GroupArch Intern Med1992152156641728930
  • ThomasFBeanKGuizeLQuentzelSArgyriadisPBenetosACombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (< 55 years) men and womenEur Heart J200223752853511922642
  • NeatonJDBlackburnHJacobsDSerum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research GroupArch Intern Med19921527149015001627030
  • EatonCBFeldmanHAAssafARPrevalence of hypertension, dyslipidemia, and dyslipidemic hypertensionJ Fam Pract199438117238289046
  • WongNDLopezVTangSWilliamsGRPrevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United StatesAm J Cardiol200698220420816828593
  • O’MearaJGKardiaSLArmonJJBrownCABoerwinkleETurnerSTEthnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA studyArch Intern Med2004164121313131815226165
  • TurnbullFEffects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsLancet200336293951527153514615107
  • StaessenJAWangJGThijsLCardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003J Hypertens20032161055107612777939
  • SeverPSDahlöfBPoulterNRPrevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialLancet200336193641149115812686036
  • BaigentCKeechAKearneyPMEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536694931267127816214597
  • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA2002288232981299712479763
  • JohnsonMLPietzKBattlemanDSBeythRJTherapeutic goal attainment in patients with hypertension and dyslipidemiaMed Care2006441394616365611
  • European Society of Hypertension-European Society of Cardiology Guidelines Committee2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032161011105312777938
  • KotsevaKWoodDDe BackerGDe BacquerDPyoralaKKeilUEUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEur J Cardiovasc Prev Rehabil200916212113719287307
  • BennerJSPollackMFSmithTWBullanoMFWilleyVJWilliamsSAAssociation between short-term effectiveness of statins and long-term adherence to lipid-lowering therapyAm J Health Syst Pharm200562141468147515998926
  • BramleyTJGerbinoPPNightengaleBSFrech-TamasFRelationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizationsJ Manag Care Pharm200612323924516623608
  • HoPMMagidDJShetterlySMImportance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary diseaseArch Intern Med2008168327127618268167
  • HoPMRumsfeldJSMasoudiFAEffect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitusArch Intern Med2006166171836184117000939
  • HoPMSpertusJAMasoudiFAImpact of medication therapy discontinuation on mortality after myocardial infarctionArch Intern Med2006166171842184717000940
  • ChapmanRHBennerJSPetrillaAAPredictors of adherence with antihypertensive and lipid-lowering therapyArch Intern Med2005165101147115215911728
  • DeziiCMA retrospective study of persistence with single-pill combination therapy vs concurrent two-pill therapy in patients with hypertensionManag Care200099 Suppl2611729417
  • PerreaultSLamarreDBlaisLPersistence with treatment in newly treated middle-aged patients with essential hypertensionAnn Pharmacother20053991401140816076920
  • TaylorAAShoheiberOAdherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapyCongest Heart Fail20039632433214688505
  • AgarwalSTangSSKRosenbergNDoes synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?Am J Ther200916211912619114872
  • NeutelJMBestermannWHDyessEMThe use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter studyJ Clin Hypertens (Greenwich)2009111223019125855
  • FlackJMVictorRWatsonKImproved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trialMayo Clin Proc2008831354518174006
  • ErdineSRoYMTseHFSingle-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)J Hum Hypertens200823319621018800143
  • PatelBVLeslieRSThiebaudPAdherence with single-pill amlodipine/atorvastatin vs a two-pill regimenVasc Health Risk Manag20084367368118827917
  • JoyceATHarrisonDJLoebelADOllendorfDAImpact of atypical antipsychotics on outcomes of care in schizophreniaAm J Manag Care2005118 SupplS254S26116180964
  • RomanoPSRoostLLJollisJGAdapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectivesJ Clin Epidemiol199346107510798410092
  • WeitzenSLapaneKLToledanoAYHumeALMorVPrinciples for modeling propensity scores in medical research: a systematic literature reviewPharmacoepidemiol Drug Saf2004131284185315386709
  • RubinDBEstimating causal effects from large data sets using propensity scoresAnn Intern Med1997127 (8 Pt 2)7577639382394
  • BennerJSGlynnRJMogunHNeumannPJWeinsteinMCAvornJLong-term persistence in use of statin therapy in elderly patientsJAMA2002288445546112132975
  • LaFleurJThompsonCJJoishVNCharlandSLOderdaGMBrixnerDIAdherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacinAnn Pharmacother2006407812741279
  • DonnellyLADoneyASMorrisADPalmerCNDonnanPTLong-term adherence to statin treatment in diabetesDiabet Med200825785085518644071
  • ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
  • BennerJSChapmanRHPetrillaAATangSSKRosenbergNSchwartzSPatients’ pill burden predicts adherence to antihypertensive and lipid-lowering therapyAm J Health Syst Pharm2009in press.
  • ChapmanRHPetrillaAABennerJSSchwartzJSTangSSKPredictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults a retrospective, cohort studyDrugs Aging2008251088589218808213
  • KulkarniSPAlexanderKPLytleBHeissGPetersonEDLong-term adherence with cardiovascular drug regimensAm Heart J2006151118519116368315
  • BangaloreSKamalakkannanGParkarSMesserliFHFixed-dose combinations improve medication compliance: a meta-analysisAm J Med2007120871371917679131
  • GrantRWO’LearyKMWeilburgJBSingerDEMeigsJBImpact of concurrent medication use on statin adherence and refill persistenceArch Intern Med2004164212343234815557413
  • GrantRWSingerDEMeigsJBMedication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims dataClin Ther200527677378116117984
  • LagiARossiAPassalevaMTCarteiACencettiSCompliance with therapy in hypertensive patientsIntern Emerg Med20061320420817120466
  • GibsonTBMarkTLMcGuiganKAAxelsenKWangSThe effects of prescription drug copayments on statin adherenceAm J Manag Care200612950951716961440
  • TairaDAWongKSFrech-TamasFChungRSCopayment level and compliance with antihypertensive medication: analysis and policy implications for managed careAm J Manag Care2006121167868317090224
  • ThiebaudPPatelBVNicholMBThe demand for statin: the effect of copay on utilization and complianceHealth Econ2008171839717585395
  • WagnerTHHeislerMPietteJDPrescription drug co-payments and cost-related medication underuseHealth Econ Policy Law20083516718634632
  • BlackburnDFDobsonRTBlackburnJLWilsonTWStangMRSemchukWMAdherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort studyCan J Cardiol200521648548815917876
  • LaRosaJHLaRosaJCEnhancing drug compliance in lipid-lowering treatmentArch Fam Med20009101169117511115225
  • KiortsisDNGiralPBruckertETurpinGFactors associated with low compliance with lipid-lowering drugs in hyperlipidemic patientsJ Clin Pharm Ther200025644545111123498
  • OgedegbeGSchoenthalerAA systematic review of the effects of home blood pressure monitoring on medication adherenceJ Clin Hypertens (Greenwich)20068317418016522994
  • FeldmanRBacherMCampbellNDroverAChockalingamAAdherence to pharmacologic management of hypertensionCan J Public Health1998895I16I189813921
  • SteinerJFProchazkaAVThe assessment of refill compliance using pharmacy records: methods, validity, and applicationsJ Clin Epidemiol19975011051169048695
  • HarmonGLefanteJKrousel-WoodMOvercoming barriers: the role of providers in improving patient adherence to antihypertensive medicationsCurr Opin Cardiol200621431031516755199
  • ShrankWHHoangTEttnerSLThe implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditionsArch Intern Med2006166333233716476874